Across Kloxxado™ nasal spray’s two PK studies, adverse reactions were reported in two subjects for each of the following: abdominal pain, asthenia, dizziness, headache, nasal discomfort, and presyncope.2 Risks include: Risk [...]
Kloxxado™ (naloxone HCl) nasal spray 8 mg is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, [...]
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit https://www.fda.gov/medwatch or call 1-800-FDA-1088.
Please contact your nearest wholesaler or call Hikma Specialty USA Inc. Customer Service at 1-877-259-6893. Contact us if you’re interested in placing a bulk order of KloxxadoTM.
Yes! Please contact us if you’re interested in placing a bulk order of KloxxadoTM.
Kloxxado™ is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the other ingredients in Kloxxado™.2
Overdose deaths appear to have accelerated during the COVID-19 pandemic, reaching 81,230 from June 2019 to May 2020, primarily driven by illicitly manufactured synthetic opioids.12 A higher dose of naloxone [...]
Kloxxado™ contains 8 mg of naloxone per spray, whereas Narcan® only contains 4 mg of naloxone per spray. Both products come with two devices per box, so with Kloxxado™ you’re [...]